Gavin MacBeath
2021
In 2021, Gavin MacBeath earned a total compensation of $1.2M as Acting Chief Executive Officer, Chief Scientific and Operating Officer at TScan Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $618,001 |
| Salary | $400,000 |
| Other | $11,839 |
| Total | $1,189,840 |
MacBeath received $618K in option awards, accounting for 52% of the total pay in 2021.
MacBeath also received $160K in non-equity incentive plan, $400K in salary and $11.8K in other compensation.
Rankings
In 2021, Gavin MacBeath's compensation ranked 8,152nd out of 12,415 executives tracked by ExecPay. In other words, MacBeath earned more than 34.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,152 out of 12,415 | 34th |
Division Manufacturing | 3,608 out of 5,505 | 35th |
Major group Chemicals And Allied Products | 1,603 out of 2,375 | 33rd |
Industry group Drugs | 1,425 out of 2,096 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 316 out of 449 | 30th |
Source: SEC filing on April 25, 2023.
MacBeath's colleagues
We found two more compensation records of executives who worked with Gavin MacBeath at TScan Therapeutics in 2021.